Koyfin Home > Directory > Health Care > Akebia Therapeutics > Other Liabilities

Akebia Therapeutics Other Liabilities Chart (AKBA)

Akebia Therapeutics annual/quarterly Other Liabilities from 2013 to 2020.
  • Akebia Therapeutics Other Liabilities for the quarter ending June 06, 2020 was $78m a 2.88% increase of 2m year over year
  • Akebia Therapeutics Other Liabilities for the last 12 months ending June 06, 2020 was $78m a 2.88% increase of 2m year over year
  • Akebia Therapeutics Annual Other Liabilities for 2019 was $65m a -46.04% decrease of -30m from 2018
  • Akebia Therapeutics Annual Other Liabilities for 2018 was $95m a -5.95% decrease of -6m from 2017
  • Akebia Therapeutics Annual Other Liabilities for 2017 was $101m a -17.16% decrease of -17m from 2016
Other Balance Sheet Metrics:
  • Akebia Therapeutics Total Assets for the quarter ending December 12, 2018 was $997m a 55.57% increase of 554m year over year
  • Akebia Therapeutics Total Equity for the quarter ending December 12, 2018 was $143m a -38.27% decrease of -55m year over year
View Chart On Koyfin

Quarterly AKBA Other Liabilities Data

06/2020$78m
03/2020$75m
12/2019$65m
09/2019$76m
06/2019$88m
03/2019$90m
12/2018$95m
09/2018$84m
06/2018$83m
03/2018$94m

Annual AKBA Other Liabilities Data

2019$65m
2018$95m
2017$101m
2016$118m
2015$0m
2014$0m
2013$0m